Pharma Excipients

News on Pharma Excipients

Melatonin hyalurosomes in collagen thermosensitive gel as a potential repurposing approach for rheumatoid arthritis management via the intra-articular route

Despite the fact that several rheumatoid arthritis treatments have been utilized, none of them achieved complete joint healing and has been accompanied by several side effects that compromise patient compliance. This study aims to provide an effective safe RA treatment with minimum side effects through the encapsulation of melatonin (MEL) in…

PVA as binder in continuous twin-screw granulation

Introduction Granulation of powder blends is a commonly applied technique for pharmaceutical formulations which have no suitable flowability or compactability or are inhomogeneous with regards to the API content. Mainly wet granulation is…

Injectable systems for long-lasting insulin therapy

Abstract Insulin therapy is the mainstay to treat diabetes characterizedd by hyperglycemia. However, its short half-life of only 4–6 min limits its effectiveness in treating chronic diabetes. Advances in recombinant DNA technology and…

InhaLac® 145 – The interview

MEGGLE announced the release of its new lactose product InhaLac® 145 yesterday. Pharma Excipients had the opportunity to speak with Dr. Constanze Müller, Manager Business Development Inhalation and one of the persons behind the…

Electroactive Polymers for On-Demand Drug Release

Abstract Conductive materials have played a significant role in advancing society into the digital era. Such materials are able to harness the power of electricity and are used to control many aspects of daily life. Conductive polymers…

Lipoid launches new product quality for LIPOID PE 18:1

Lipoid is dedicated to continuously optimizing its production processes and product portfolio. For their product LIPOID PE 18:1/18:1 (DOPE), they are now launching a new product quality. The new product quality allows rapid and complete…